Back
Caribou Biosciences Quote, Financials, Valuation and Earnings
Sponsored
CRBU
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
52
CRBU
Caribou Biosciences
Last Price:
2.08
Seasonality Move:
-20.16%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerCaribou Biosciences Price Quote
$2.08
+0.01 (+0%)
(Updated: September 20, 2024 at 3:35 AM ET)
Caribou Biosciences Key Stats
Buy
52
Caribou Biosciences (CRBU)
is a Buy
Day range:
$2.07 - $2.22
52-week range:
$1.50 - $8.33
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.53
P/B ratio:
0.61%
Volume:
732K
Avg. volume:
936.8K
1-year change:
-62.02%
Market cap:
$188M
Revenue:
$34.5M
EPS:
$-1.4
How Much Does Caribou Biosciences Make?
-
How Much Are Caribou Biosciences's Sales Annually?
CRBU Revenues are $34.5M -
How Much Profit Does Caribou Biosciences's Make A Year?
CRBU net income is -$102.1M
Is Caribou Biosciences Growing As A Company?
-
What Is Caribou Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.08% -
What Is Caribou Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Caribou Biosciences Stock Price Performance
-
Did Caribou Biosciences Stock Go Up Last Month?
Caribou Biosciences share price went down by -5.05% last month -
Did CRBU's Share Price Rise Over The Last Year?
CRBU share price fell by -62.02% over the past 1 year
What Is Caribou Biosciences 52-Week High & Low?
-
What Is Caribou Biosciences’s 52-Week High Share Price?
Caribou Biosciences has traded as high as $8.33 over the past 52 weeks -
What Is Caribou Biosciences’s 52-Week Low Share Price?
Caribou Biosciences has traded as low as $1.50 over the past 52 weeks
Caribou Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Caribou Biosciences?
-
How Much Debt Does Caribou Biosciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Caribou Biosciences Have?
Cash and short term investments quarterly total is $261.6M -
What Is Caribou Biosciences’s Book Value Per Share?
Book value per share is 3.44
Is Caribou Biosciences Cash Flow Positive?
-
What Is CRBU Cash Flow From Operations?
Cash flow from operations (TTM) is -$120.2M -
What Is Caribou Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $147.7M -
What Is Caribou Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$55.8M
Caribou Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
CRBU return on invested capital is -36.52% -
What Is Caribou Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -30.57% -
What Is CRBU Return On Equity?
ROE is a measure of profitability and is -36.52%
Caribou Biosciences Earnings Date & Stock Price
-
What Is Caribou Biosciences's Stock Price Today?
A single share of CRBU can be purchased today for 2.07 -
What Is Caribou Biosciences’s Stock Symbol?
Caribou Biosciences trades on the nasdaq under the ticker symbol: CRBU -
When Is Caribou Biosciences’s Next Earnings Date?
The next quarterly earnings date for Caribou Biosciences is scheduled on November 7, 2024 -
When Is CRBU's next ex-dividend date?
Caribou Biosciences's next ex-dividend date is September 20, 2024 -
How To Buy Caribou Biosciences Stock?
You can buy Caribou Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Caribou Biosciences Competitors
-
Who Are Caribou Biosciences's Competitors?
Below is a list of companies who compete with Caribou Biosciences or are related in some way:
Caribou Biosciences Dividend Yield
-
What Is CRBU Dividend Yield?
Caribou Biosciences’s dividend yield currently is 0% -
What Is Caribou Biosciences’s Payout Ratio?
Caribou Biosciences’s payout ratio is 0% -
When Did Caribou Biosciences Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Caribou Biosciences’s Dividend Per Share?
Caribou Biosciences pays a dividend of $0.00 per share
Caribou Biosciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0.91% |
Revenue: | -7.75% | 14.01% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 15.63 |
Upside from Last Price: | 654.83% |